Loading
Latest filing published 23 Aug 2023 for Harvard Apparatus Regenerative Technology, Inc., €27k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of James E. Shmerling in Harvard Apparatus Regenerative Technology, Inc., where the filings describe the role as board member. The record holds 2 filings, for trades running from 12 May 2022 to 21 August 2023.
On the market, this insider has only ever bought: 2 purchases, €124k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2023 to date brings 1 purchase and no sales.
The record was last updated on 23 August 2023 with an open-market purchase (€27k) in Harvard Apparatus Regenerative Technology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations